How to buy Cyclo Therapeutics stock

Cyclo Therapeutics stock is currently available to purchase as an over-the-counter (OTC) stock on the OTCQB. But many popular brokerages don't offer access to OTC stocks.

Cyclo has recently filed with the SEC to list stock on the Nasdaq Capital Market. This will make it possible to buy its stock from any major stock broker.

How to buy shares in Cyclo Therapeutics

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Cyclo Therapeutics. Find the stock by name or ticker symbol: CTDH. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Cyclo Therapeutics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Cyclo Therapeutics, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Cyclo Therapeutics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Active investors

Webull

Our top pick for

Building a portfolio

Sofi Invest

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for active investors. We picked Webull for this category because its platform offers features that cater to advancing investors as well as beginners. The desktop app is outfitted with an extensive set of research tools, the mobile app gets high grades from users and traders can test strategies with a paper-trading feature.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.

What's in this guide?

1. CTDH shares summary
2. Compare share dealing platforms
3. Is CTDH stock a buy or sell?
4. Stock performance over time
5. Cyclo Therapeutics's financials
6. How volatile are CTDH shares?
7. Does Cyclo Therapeutics pay a dividend?
8. Have CTDH shares ever split?
9. Other common questions

Cyclo Therapeutics share price

Use our graph to track the performance of CTDH stocks over time.

Cyclo Therapeutics shares at a glance

• Key figures

Information last updated 2021-01-22.

52-week range	USD$3.55 - USD$30
50-day moving average	USD$6.0983
200-day moving average	USD$10.3403
Wall St. target price	USD$1.25
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.059

Buy Cyclo Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Webull		$0	Stocks, Options, ETFs	$0	0%	Get two free stock valued between $2.50 and $250 Open an account	Margin financing rates start at 3.99%. No monthly subscription fees for margin.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options, Mutual funds	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Cyclo Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Cyclo Therapeutics, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Have Cyclo Therapeutics's shares ever split?

Cyclo Therapeutics's shares were split on a 1:100 basis on 9 December 2020. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cyclo Therapeutics shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Cyclo Therapeutics shares which in turn could have impacted Cyclo Therapeutics's share price.

Cyclo Therapeutics share price volatility

Over the last 12 months, Cyclo Therapeutics's shares have ranged in value from as little as $3.55 up to $30. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Cyclo Therapeutics's is -0.8845. This would suggest that Cyclo Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Cyclo Therapeutics has bucked the trend.

To put Cyclo Therapeutics's beta into context you can compare it against those of similar companies.

• Inovio Pharmaceuticals (INO.US): 0.9963
• Regeneron Pharmaceuticals (REGN.US): 0.1569
• Novavax (NVAX.US): 1.5848

Cyclo Therapeutics overview

Cyclo Therapeutics, Inc., a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. It has a collaboration with the Chattanooga Center for Neurologic Research. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in October 2019. Cyclo Therapeutics, Inc. was founded in 1990 and is based in Gainesville, Florida.

Frequently asked questions

• What percentage of Cyclo Therapeutics is owned by insiders or institutions?

  Currently 1.019% of Cyclo Therapeutics shares are held by insiders and 0.102% by institutions.

• How many people work for Cyclo Therapeutics?

  Latest data suggests 5 work at Cyclo Therapeutics.

• When does the fiscal year end for Cyclo Therapeutics?

  Cyclo Therapeutics's fiscal year ends in December.

• Where is Cyclo Therapeutics based?

  Cyclo Therapeutics's address is: 6714 NW 16th Street, Gainesville, FL, United States, 32563

• What is Cyclo Therapeutics's ISIN number?

  Cyclo Therapeutics's international securities identification number is: US23254X1028

• What is Cyclo Therapeutics's CUSIP number?

  Cyclo Therapeutics's Committee on Uniform Securities Identification Procedures number is: 12642Q101